Southampton, UK, 1 July 2021—Building on its global leadership in toric contact lenses, CooperVision has introduced an even broader range of expanded parameters for its trusted Biofinity® XR toric contact lenses. The substantial addition of sphere powers from ±10.50D to ±20.00D nearly doubles the number of available prescription options specific to this lens to 32,796, making it easier than ever for eye care professionals to fit virtually any astigmatic patient.
Biofinity® toric
|
Sphere Power (DS) |
Cylinder Power (DC) |
Axes ° |
|
+8.00D to -10.00D (0.50 steps after +/-6.00) |
-0.75, -1.25, -1.75, -2.25, |
10° to 180° (in 10° steps) |
Biofinity® XR toric
|
Sphere Power (DS) |
Cylinder Power (DC) |
Axes ° |
|
+8.50 to +20.00D and -10.50 to -20.00 (0.50 steps) |
-0.75, -1.25, -1.75, -2.25, |
5° to 180° (in 5° steps) |
|
Sphere Power (DS) |
Cylinder Power (DC) |
Axes ° |
|
+20.00 to -20.00 (0.50 steps after +/-6.00) |
-2.75, -3.25, -3.75, -4.25, -4.75, -5.25, -5.75 |
5° to 180° (in 5° steps) |
“This latest addition to the Biofinity® portfolio highlights our commitment to supporting eye care professionals to enable even more of their patients to enjoy the freedom and confidence that contact lenses bring” said Mark Draper, Director of Marketing and National Accounts, CooperVision UK & Ireland. “The Biofinity® family of contact lenses now has over 20x more prescription options than any other family of soft contact lenses from other main manufacturers.2”
Biofinity® XR toric is a fully cast-moulded made-to-order lens that features Optimised Toric Lens Geometry™, which provides the same uniform horizontal ISO thickness and optimised ballast band design as Biofinity® toric.
To help streamline the fitting process and minimise chair time, CooperVision offers the OptiExpert® fitting app. The easy-to-use app includes a toric calculator which calculates and suggests the recommended Biofinity® toric or Biofinity® XR toric contact lens for each patient.
For more information on Biofinity® XR toric, visit coopervision.co.uk/practitioner/contact-lenses/biofinity-xr-toric
###
References:
1. CVI data on file 2020. Rx coverage database; 14 to 70 years.
2. CVI data on file 2020. Based on prescription options available across all soft lenses in
sphere, toric, multifocal and toric multifocal, SiHy and hydrogel, stock and made-to-order from 4 main manufacturers in UK, Germany, Italy and France.
Cosmetic & Photochromatic CLs not included. Multiple base curve variants not included. * Includes sphere, cylinder, axis and ADD combinations.
About CooperVision
CooperVision, a division of CooperCompanies (NYSE:COO), is one of the world’s leading manufacturers of contact lenses. The company produces a full array of daily disposable, two-week and monthly soft contact lenses that feature advanced materials and optics, and premium rigid gas permeable lenses for orthokeratology and scleral designs. CooperVision has a strong heritage of addressing the toughest vision challenges such as astigmatism, presbyopia, childhood myopia, and highly irregular corneas; and offers the most complete portfolio of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com.
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.
Media Contact
MEDIA CONTACT: Fiona Healey / Carolina Filipe
CONTACT DETAILS: fiona.healey@fivebyfiveglobal.com
carolina.filipe@fivebyfiveglobal.com
02380 828525